These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 6350653)
21. Adaptation to human and animal organ allografts: reconsideration of a hypothesis. Miller J; Lifton J; DeWolf WC; Hattler BG Transplant Proc; 1976 Jun; 8(2):217-24. PubMed ID: 132726 [No Abstract] [Full Text] [Related]
24. Some comments on lymphocyte-mediated cytotoxicity and blocking serum activity in allograft tolerance. Hellström I; Hellström KE Johns Hopkins Med J Suppl; 1974; 3():301-5. PubMed ID: 4607384 [No Abstract] [Full Text] [Related]
25. Advantages of F(ab')2 fragments of anti-CD3 monoclonal antibody as compared to whole antibody as immunosuppressive agents in mice. Hirsch R; Bluestone JA; Bare CV; Gress RE Transplant Proc; 1991 Feb; 23(1 Pt 1):270-1. PubMed ID: 1824981 [No Abstract] [Full Text] [Related]
26. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement. Thierfelder S; Cobbold S; Kummer U; Waldmann H; Schuh R Exp Hematol; 1985 Oct; 13(9):948-55. PubMed ID: 2864278 [TBL] [Abstract][Full Text] [Related]
27. Monitoring of T-lymphocyte regeneration following allogeneic bone marrow transplantation using monoclonal antibodies. Gratama JW; Bolhuis RL Neth J Med; 1985; 28(3):128-33. PubMed ID: 3157071 [No Abstract] [Full Text] [Related]
28. Detection of lymphocyte subsets in renal graft biopsy by monoclonal antibodies. Vangelista A; Frascá G; Nanni-Costa A; Bonomini V Proc Eur Dial Transplant Assoc; 1983; 20():315-9. PubMed ID: 6361744 [TBL] [Abstract][Full Text] [Related]
30. Treatment of aplastic anemia: results with bone marrow transplantation, antithymocyte globulin, and a monoclonal anti-T cell antibody. Champlin R; Ho W; Bayever E; Winston DJ; Lenarsky C; Feig SA; Gale RP Prog Clin Biol Res; 1984; 148():227-38. PubMed ID: 6379661 [No Abstract] [Full Text] [Related]
31. [Monoclonal antibodies and their clinical use]. Rytwiński K Pediatr Pol; 1986 Feb; 61(2):116-22. PubMed ID: 3529024 [No Abstract] [Full Text] [Related]
32. Tolerance induction in a fully allogeneic combination using anti-T cell receptor-alpha beta monoclonal antibody, low dose irradiation, and donor bone marrow transfusion. Nomoto K; Yung-Yun K; Omoto K; Umesue M; Murakami Y; Matsuzaki G; Nomoto K Transplantation; 1995 Feb; 59(3):395-401. PubMed ID: 7871570 [TBL] [Abstract][Full Text] [Related]
33. Acute cellular rejection during effective early prophylactic OKT3 monoclonal antibody treatment after renal transplantation. Haak HH; Weening JJ; Rischen-Vos J; Daha MR; van Es LA; van der Woude FJ Transplantation; 1989 Aug; 48(2):352-4. PubMed ID: 2526973 [No Abstract] [Full Text] [Related]
34. Monocyte hemolytic activity as an immunologic indicator of allograft rejection in rat skin transplantation. Moutabarrik A; Ishibashi M; Kameoka H; Takahara S; Kokado Y; Jiang H; Takano Y; Sonoda T Transplant Proc; 1992 Feb; 24(1):403-7. PubMed ID: 1347184 [No Abstract] [Full Text] [Related]
35. In vitro analysis of donor bone marrow following monoclonal antibody treatment for the prevention of acute graft versus host disease. Kohler PC; Erickson C; Finlay JL; Trigg ME; Edwards B; Hong R; Hank JA; Billing R; Bozdech M; Sondel PM Cancer Res; 1986 Oct; 46(10):5413-8. PubMed ID: 3530439 [TBL] [Abstract][Full Text] [Related]
36. Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb. Patel NC; Chinen J; Rosenblatt HM; Hanson IC; Brown BS; Paul ME; Abramson SL; Ritz J; Shearer WT J Allergy Clin Immunol; 2008 Dec; 122(6):1185-93. PubMed ID: 19084111 [TBL] [Abstract][Full Text] [Related]
38. Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis. Small TN; Avigan D; Dupont B; Smith K; Black P; Heller G; Polyak T; O'Reilly RJ Biol Blood Marrow Transplant; 1997 Jun; 3(2):65-75. PubMed ID: 9267666 [TBL] [Abstract][Full Text] [Related]
39. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts. Soulillou JP; Cantarovich D; Le Mauff B; Giral M; Robillard N; Hourmant M; Hirn M; Jacques Y N Engl J Med; 1990 Apr; 322(17):1175-82. PubMed ID: 2157982 [TBL] [Abstract][Full Text] [Related]
40. Graft versus host disease prophylaxis today. Martelli MF; Aversa F Bone Marrow Transplant; 1991; 7 Suppl 2():112-6. PubMed ID: 1908726 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]